News
State Dept. mum on next steps after India ruling
Spokesperson reiterates support for LGBT rights overseas
Supreme Court of India (Photo by Legaleagle86; courtesy Wikimedia Commons)
State Department spokesperson Jen Psaki wouldn’t speculate Wednesday about how the U.S. might encourage India to repeal its law criminalizing homosexual acts when asked about the recent court ruling upholding the colonial-era law.
Under questioning from the Washington Blade, Psaki declined to speculate about the potential options to encourage additional steps in India after she reiterated the Obama administration’s commitment to LGBT rights overseas.
“That’s a decision that the Indian government would make,” Psaki said. “We, obviously, don’t make decisions on behalf of other governments and their legislation. So, I expressed our deep concern about any efforts around the world to not recognize that LGBT rights are human rights and that’s a message we’ll continue to make.”
Earlier in the day, the India Supreme Court overturned a lower court ruling from 2009 that decriminalized the same-sex relations between two men, which was previously illegal under a colonial-era law known as section 377. With the law back in place, individuals found guilty of “unnatural offenses” in the world’s second most populous country could face 10 years in prison.
Psaki said the State Department is “aware of” the decision in response to a first question about the ruling from a reporter during her daily news briefing,
But Psaki responded to the decision initially only by speaking broadly about the Obama administration’s support for LGBT rights, referencing a statement from Secretary of State John Kerry on Human Rights Day.
“We oppose any action that criminalizes consensual same-sex conduct between adults,” Psaki said. “LGBT rights are human rights. That’s something you heard Secretary Kerry say and Secretary Clinton say before him. And we call on all governments to advance equality for LGBT individuals around the world.”
It took questioning from another reporter for Psaki to clarify that U.S. concern with anti-sodomy laws “whether it’s India, or any other country” applies to the recent ruling.
“Any action that criminalizes consensual same-sex conduct between adults, that doesn’t recognize that fundamental freedoms include their right to sexual orientation, those are issues that we certainly would be concerned about as we are here,” Psaki said.
Asked whether the State Department was planning to reach out to the Indian government about the issue, Psaki wouldn’t make any specific predictions, but said human rights issues come up in conversations.
“Well, we consistently bring up human rights issues with most countries we meet with,” Psaki said. “I don’t have any specific recent call or meeting to read out for all of you, but certainly that’s something we’re happy to express publicly and privately.”
Top U.S. officials just recently had the opportunity to speak with Indian officials.
As part of her initial response speaking generally about news related to India, Psaki said Secretary of State John Kerry and other high-ranking State Department officials met on Tuesday with Indian Foreign Secretary Sujatha Singh and agreed to an expansion of strategic partnerships.
“The United States and India agreed … to strengthen new U.S.-India cooperation on training U.S. peacekeepers to develop support for the department’s own peace operations initiative,” she said. “The United States also accepted India’s invitation to serve as a partner country for India’s technology summit and expo in New Delhi in the fall of 2014, further intensifying our broad scientific cooperation.”
Asked whether the Supreme Court decision came up during this discussion, Psaki said she believes it happened before the ruling was handed down. When another reporter mentioned other related meetings were taking place today, Psaki said she’d have to check to verify that and whether any discussions about the ruling took place.
“I don’t have any other comment for you on the Supreme Court case than what I just offered or any other expectations of steps,” Psaki said. “That’s obviously steps the Indian government would take.”
After a reporter pointed out that the State Department would make threats aimed at Ukraine after it used violence to stop peaceful protests, but that it won’t take similar action in the India case, Psaki said the situations were different.
“Obviously, the events in Ukraine, we expressed our deep concern and the reasons why,” Psaki said. “And, as you know, we don’t group every country and everything that happens into the same category. Every circumstance is different.”
A transcript of the exchange follows:
U.S. Department of State (Photo public domain)
QUESTION: Thank you. You must have seen the Indian Supreme Court decision criminalizing homosexuality, which has sent shockwaves in the global LGBT community. And it’s more important, because only yesterday, Secretary Kerry issued a statement on Human Rights Day, and in which he mentioned LGBT. So what is the reaction that – and especially because the Indian foreign secretary is in town?
MS. PSAKI: Mm-hmm. Well, we, of course, are aware of the Supreme Court decision. The United States places great importance on the protection of human rights and fundamental freedoms of all people. And as you saw and as you referenced in the Secretary’s statement yesterday, that includes lesbian, gay, bisexual, and transgender persons around the world. We oppose any action that criminalizes consensual same-sex conduct between adults. LGBT rights are human rights. That’s something you’ve heard Secretary Kerry say, I believe Secretary Clinton say before him, and we call on all governments to advance equality for LGBT individuals around the world.
I know you asked me about the visit of the foreign secretary. I’m happy to give a readout of that, if that’s helpful as well. Secretary Kerry and Deputy Secretary Burns met yesterday with Indian Foreign Secretary Singh to discuss ways to deepen the U.S.-India Strategic Partnership and consult on regional issues. Foreign Secretary Singh also met with Acting Under Secretary Rose Gottemoeller, Assistant Secretary for South and Central Asia Nisha Biswal, and other senior officials.
The United States and India agree to joint principles to strengthen India-U.S. cooperation on training UN peacekeepers, developed with support from the Department’s Global Peace Operations Initiative. The United States also accepted India’s invitation to serve as a partner country for India’s technology summit and expo in New Delhi in the fall of 2014, further intensifying our broad scientific cooperation.
QUESTION: Thank you. Are you planning to reach out to the Indian Government to express your – directly about what needs to be done? Because if you see the atmosphere there, the political parties, the pressure, and – it is not just a vague Supreme Court decision.
MS. PSAKI: Well, we have – we consistently bring up human rights issues with most countries we meet with, and I don’t have any specific recent call or meeting to read out for all of you, but certainly, that’s something we’re happy to express publicly and privately as needed.
QUESTION: Back on India —
QUESTION: Well, in that meeting between the top diplomat for the Administration and his Deputy and the Indian foreign secretary, this didn’t come up?
MS. PSAKI: That happened yesterday. I don’t – I’m not aware of when – I believe this decision may have been today, the Supreme Court decision.
QUESTION: But she still has a meeting today too in the building.
MS. PSAKI: Hmm?
QUESTION: She had a meeting today also. Was this issue brought up with her?
MS. PSAKI: Today? With – who was the meeting with today?
QUESTION: I don’t know, but I think she had —
QUESTION: But she’s in town.
QUESTION: — some meetings here today also.
MS. PSAKI: I have to check on that. I was under the impression that most of the meetings were yesterday, but I’m happy to check, and if there were meetings today, we can check if this issue came up.
QUESTION: All right. And then —
QUESTION: Yeah, but the question —
QUESTION: — in the initial – in your initial response, I didn’t hear you actually give any reaction to what the decision actually was. I’m presuming that you think it’s a bad ruling by the Supreme Court, but I didn’t hear you say that.
MS. PSAKI: Well, we —
QUESTION: Can you go ahead – can you say that?
MS. PSAKI: I believe by saying we oppose any action that criminalizes consensual same-sex conduct between adults in general around the world, I think I was pretty clear about what our view is.
QUESTION: So what do you think about the – specifically about the Indian Supreme Court decision?
MS. PSAKI: I think —
QUESTION: I’m looking for something that’s got the word “India” in the answer, other than just —
MS. PSAKI: Matt, I’m not sure I have much more to add other than to convey that any legislation around the world, whether it’s India or any other country that criminalizes —
QUESTION: But this isn’t legislation.
MS. PSAKI: — I’m sorry – any action that criminalizes consensual same-sex conduct between adults that doesn’t recognize that fundamental freedoms of people include their right to sexual orientation – those are issues that we certainly would be concerned about, as we are here.
QUESTION: So you are expressing concern about the Supreme Court decision in India on this case?
MS. PSAKI: Correct.
QUESTION: Okay.
MS. PSAKI: Does the supreme —
QUESTION: Clarify it one more time.
MS. PSAKI: Sure.
QUESTION: You are opposed to the Supreme Court decision and you are going to raise this issue with the Indian Government, right?
MS. PSAKI: I think I expressed our concern about any cases along these lines. We are in regular touch about these issues and others with India. I don’t have anything specific to read out for you in terms of future meetings or conversations about this.
…
QUESTION: Yeah. Does the United States expect India to – the parliament – with respect to the parliament, does it expect the Indian parliament to repeal that law?
MS. PSAKI: I don’t have any other comment for you on the Supreme Court case than what I’ve just offered or any other expectation of steps. That’s obviously steps the Indian Government would take.
QUESTION: Is there any actions at all the Supreme Court – is there any options at all the State Department is examining to encourage India to repeal that law?
MS. PSAKI: That’s a decision that the Indian Government would make. We obviously don’t make decisions on behalf of other governments and their legislation. So I expressed our deep concern about any efforts around the world to not recognize that LGBT rights are human rights, and that’s a message we’ll continue to convey.
QUESTION: Well, the only problem with that is that you’re threatening sanctions on Ukraine, or saying that they’re a possibility because they’re violating people’s human rights and not listening to the – not listening to the people. And yet here with India, it’s not even clear whether this has – has come up, will come up, or will ever come up with the Indian Government. And in fact, the meeting – the readout that you gave of the meetings yesterday said that everything with India is full speed ahead, and we’re intensifying our relationship, and —
…
MS. PSAKI: Those meetings were yesterday. I think I expressed pretty clearly our opposition to this. In terms of what steps would be taken by a government on a Supreme Court case, that’s not something I would have a comment on. Obviously, the events in Ukraine we’ve expressed our deep concern about, and the reasons why. And as you know, we don’t group every country and everything that happens into the same category. Every circumstance is different.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Rehoboth Beach
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
$4.5 million listing includes real estate; business sold separately
Gay gasps could be heard around the DMV earlier this week when a real estate listing for Rehoboth Beach’s iconic Blue Moon bar and restaurant hit social media.
Take a breath. The Moon is for sale but the longtime owners are not in a hurry and are committed to preserving its legacy as a gay-friendly space.
“We had no idea the interest this would create,” Tim Ragan, one of the owners, told the Blade this week. “I guess I was a little naive about that.”
Ragan explained that he and longtime partner Randy Haney are separating the real estate from the business. The two buildings associated with the sale are listed by Carrie Lingo at 35 Baltimore Ave., and include an apartment, the front restaurant (6,600 square feet with three floors and a basement), and a secondary building (roughly 1,800 square feet on two floors). They are listed for $4.5 million.
The bar and restaurant business is being sold separately; the price has not been publicly disclosed.
But Ragan, who has owned the Moon for 20 years, told the Blade nothing is imminent and that the Moon remains open through the holidays and is scheduled to reopen for the 2026 season on Feb. 10. He has already scheduled some 2026 entertainment.
“It’s time to look for the next people who can continue the history of the Moon and cultivate the next chapter,” Ragan said, noting that he turns 70 next year. “We’re not panicked; we separated the building from the business. Some buyers can’t afford both.”
He said there have been many inquiries and they’ve considered some offers but nothing is firm yet.
Given the Moon’s pioneering role in queering Rehoboth Beach since its debut 44 years ago in 1981, many LGBTQ visitors and residents are concerned about losing such an iconic queer space to redevelopment or chain ownership.
“That’s the No. 1 consideration,” Ragan said, “preserving a commitment to the gay community and honoring its history. The legacy needs to continue.” He added that they are not inclined to sell to one of the local restaurant chains.
You can view the real estate listing here.
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
